These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 25713905)
21. Epidermal growth factor activates nuclear factor-kappaB in human proximal tubule cells. Häussler U; von Wichert G; Schmid RM; Keller F; Schneider G Am J Physiol Renal Physiol; 2005 Oct; 289(4):F808-15. PubMed ID: 15798085 [TBL] [Abstract][Full Text] [Related]
22. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell. Liu X; Yang Y; Zhang X; Xu S; He S; Huang W; Roberts MS J Gastroenterol Hepatol; 2010 Feb; 25(2):420-6. PubMed ID: 19793165 [TBL] [Abstract][Full Text] [Related]
23. N-Benzoyl-12-nitrodehydroabietylamine-7-one, a novel dehydroabietylamine derivative, induces apoptosis and inhibits proliferation in HepG2 cells. Lin LY; Bao YL; Chen Y; Sun LG; Yang XG; Liu B; Lin ZX; Zhang YW; Yu CL; Wu Y; Li YX Chem Biol Interact; 2012 Aug; 199(2):63-73. PubMed ID: 22743618 [TBL] [Abstract][Full Text] [Related]
24. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma. Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells. Xu D; He XX; Chang Y; Sun SZ; Xu CR; Lin JS Hepatogastroenterology; 2012; 59(120):2367-73. PubMed ID: 22773266 [TBL] [Abstract][Full Text] [Related]
26. Loss of EGF-dependent cell proliferation ability on radioresistant cell HepG2-8960-R. Saito Y; Abiko R; Kishida A; Kuwahara Y; Yamamoto Y; Yamamoto F; Fukumoto M; Ohkubo Y Cell Biochem Funct; 2015 Mar; 33(2):73-9. PubMed ID: 25663666 [TBL] [Abstract][Full Text] [Related]
27. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells. Zhou Z; Lu X; Zhu P; Zhu W; Mu X; Qu R; Li M Biochem Biophys Res Commun; 2012 Apr; 420(2):336-42. PubMed ID: 22425983 [TBL] [Abstract][Full Text] [Related]
28. Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1. Li Y; Zhu W; Li J; Liu M; Wei M Oncol Rep; 2013 Dec; 30(6):2820-8. PubMed ID: 24064760 [TBL] [Abstract][Full Text] [Related]
29. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis. Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043 [TBL] [Abstract][Full Text] [Related]
30. Effect of intracellular pH and two growth factors, epidermal growth factor and human hepatocyte growth factor, on DNA synthesis in non-regenerating and regenerating hepatocytes and hepatoma cells. Yada K Osaka City Med J; 1994 Dec; 40(2):53-69. PubMed ID: 7862427 [TBL] [Abstract][Full Text] [Related]
31. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells. Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843 [TBL] [Abstract][Full Text] [Related]
32. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2. Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350 [TBL] [Abstract][Full Text] [Related]
33. [Study on inhibitory effect of triterpenoid saponin from Ardisia japonica TSP02 on proliferation and metastasis of human hepatocellular carcinoma cells and its mechanism]. Zhao CY; Hui LP; He L; Li Q Zhongguo Zhong Yao Za Zhi; 2013 Mar; 38(6):861-5. PubMed ID: 23717968 [TBL] [Abstract][Full Text] [Related]
34. [Regulatory effect of ginsenoside Rh2 on HDAC1/2 activity and cyclin in human erythroleukemia K562 cells]. Xia J; Chen D; Zuo G; Wei Q; You Z; Li D; Liu Z; Li J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1062-6. PubMed ID: 25270209 [TBL] [Abstract][Full Text] [Related]
35. Effects of IFN-gamma, TNF-alpha and EGF on the expression of HLA class I antigen and the proliferation of human hepatocellular carcinoma HepG2 cells. Wang D; Yang E; Cheng LY Anticancer Res; 1997; 17(1A):181-8. PubMed ID: 9066649 [TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor induces cell cycle arrest and apoptosis of squamous carcinoma cells through reduction of cell adhesion. Cao L; Yao Y; Lee V; Kiani C; Spaner D; Lin Z; Zhang Y; Adams ME; Yang BB J Cell Biochem; 2000 Apr; 77(4):569-83. PubMed ID: 10771513 [TBL] [Abstract][Full Text] [Related]
37. EGF Protects Cells Against Dox-Induced Growth Arrest Through Activating Cyclin D1 Expression. Yao CX; Shi JC; Ma CX; Xiong CJ; Song YL; Zhang SF; Zhang SF; Zang MX; Xue LX J Cell Biochem; 2015 Aug; 116(8):1755-65. PubMed ID: 25736800 [TBL] [Abstract][Full Text] [Related]
38. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma. Liu Y; Poon RT; Shao W; Sun X; Chen H; Kok TW; Fan ST Cancer Lett; 2007 Apr; 248(1):32-40. PubMed ID: 16837130 [TBL] [Abstract][Full Text] [Related]
39. Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis. Yamamoto M; Tamakawa S; Yoshie M; Yaginuma Y; Ogawa K Mol Carcinog; 2006 Dec; 45(12):901-13. PubMed ID: 17013836 [TBL] [Abstract][Full Text] [Related]
40. [Effect of brain-derived neurotrophic factor on in vitro metastasis of hepatocellular carcinoma cell line HepG2]. Xiao ZY; Wang YD; Chen XP Ai Zheng; 2006 Mar; 25(3):287-91. PubMed ID: 16536980 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]